The U.S. Food and Drug Administration (FDA) has approved a wearable medical device used in combination with a standard chemotherapy regimen for the treatment of adult patients with locally advanced ...
The US Nuclear Regulatory Commission has approved a new license that allows TRISO-X to manufacture advanced nuclear fuel in the United States. The approval clears the way for commercial production of ...
Please provide your email address to receive an email when new articles are posted on . FDA has approved a portable device for patients with locally advanced pancreatic cancer. A phase 3 trial showed ...
MORRIS PLAINS, N.J., Feb. 11, 2026 /PRNewswire/ -- Solstice Advanced Materials (NASDAQ: SOLS), a global leader in high-performance specialty materials, today announced that its Board of Directors has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results